regulatory
confidence high
sentiment positive
materiality 0.60
Hoth Therapeutics regains Nasdaq minimum bid price compliance; delisting risk removed
Hoth Therapeutics, Inc.
- Received Nasdaq notice on Nov 9, 2022, confirming compliance with $1.00 minimum bid price rule.
- Closing bid price at or above $1.00 for 10 consecutive business days (Oct 26 – Nov 8, 2022).
- Previously notified of deficiency on Dec 30, 2021; now delisting risk is eliminated.
- Compliance regained under Nasdaq Listing Rule 5550(a)(2); matter is closed.